Q-omics provides the consensus-scored LINC00313 profile across patient tissues and cancer cell-line models. LINC00313 expression is associated with patient survival in 28 of 34 cancer types, with the highest sampling consensus in UCEC. Among the 18 cancer types available for tumor–normal comparison, LINC00313 is differentially expressed in 9, with the highest sampling consensus in HNSC. Additionally, LINC00313 RNA expression shows 7,625 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight UCEC, HNSC, and THYM as cancer lineages where LINC00313 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC00313 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC00313 survival associations across molecular data types. LINC00313 RNA expression shows survival associations in the most cancer types (28). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC00313 RNA expression–survival associations across cancer types. High LINC00313 expression shows unfavorable associations in UCEC, KIRC, LUAD, MESO, KIRP and LUSC. The UCEC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify UCEC as the clearest survival context for LINC00313 RNA expression.
This table summarizes LINC00313 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 9. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC00313. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC00313 shows lower tumor expression in PRAD and higher tumor expression in HNSC, KIRC, THCA, BLCA and LUAD. The HNSC box plot shows higher LINC00313 RNA expression in tumor versus normal tissue (log2 FC = +0.063, t-test p < 0.001).
This table shows molecular features associated with LINC00313 in patient tissues and cancer cell lines. In patient samples, LINC00313 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
